Article Text

Download PDFPDF
The cognitive behavioural analysis system of psychotherapy prevented recurrence in chronic major depression

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


 
 Q In patients with chronic major depressive disorder (MDD), does the cognitive behavioural analysis system of psychotherapy [CBASP] prevent recurrence?

Clinical impact ratings Psychiatry ★★★★★★☆ GP/FP/Mental health ★★★★★☆☆

METHODS

Embedded ImageDesign:

randomised controlled trial.

Embedded ImageAllocation:

{concealed*}.

Embedded ImageBlinding:

blinded ({data collectors} and outcome assessors).*

Embedded ImageFollow up period:

1 year maintenance phase (after 12 wks in a treatment phase and 16 wks in a continuation phase).

Embedded ImageSetting:

12 academic centres in the US.

Embedded ImagePatients:

82 patients who were 18–75 years of age (mean age 45 y, 67% women); began the treatment phase with a DSM-IV diagnosis of MDD (duration ⩾2 y) and a score ⩾20 on the 24 item Hamilton Rating Scale for Depression (HRSD-24); and responded to CBASP alone during the treatment …

View Full Text

Footnotes

  • * See glossary.

  • Information provided by author.

  • For correspondence: Dr D N Klein, State University of New York at Stony Brook, Stony Brook, NY, USA. dkleinnotes.cc.sunysb.edu

  • Source of funding: Bristol-Myers Squibb.